Subpopulations (%)

Patients with alveolar RMS

Control group

Р

CD3+ HLADR+

47.7 ± 13.0 (n = 4)

12.5 ± 2.0 (n = 15)

0.014

CD8+ HLADR+

25.2 ± 15.0 (n = 3)

8.9 ± 1.4 (n = 11)

0.049

CD3+ CD4+

24.8 ± 3.9 (n = 4)

39.3 ± 2.8 (n = 14)

0.023

CD3+ CD28+

15.3 ± 12.6 (n = 3)

60.5 ± 9.8 (n = 11)

0.046

γδTCR Т cells

20.4 ± 3.8 (n = 3)

9.6 ± 1.5 (n = 10)

0.008